Works matching IS 1462-8902 AND VI 27 AND IP 2 AND DT 2025

Results: 61
    1
    2
    3
    4
    5

    Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 933, doi. 10.1111/dom.16093
    By:
    • Addala, Ananta;
    • Ritter, Victor;
    • Schneider‐Utaka, Aika K.;
    • Alamarie, Selma A.;
    • Pang, Erica;
    • Balistreri, Ilenia;
    • Shaw, Blake;
    • Bishop, Franziska K.;
    • Zaharieva, Dessi P.;
    • Prahalad, Priya;
    • Desai, Manisha;
    • Maahs, David M.;
    • Hood, Korey K.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Incidence of diabetes mellitus following hospitalisation for COVID‐19 in the United Kingdom: A prospective observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 767, doi. 10.1111/dom.16071
    By:
    • Tyrer, Freya;
    • Gharibzadeh, Safoora;
    • Gillies, Clare;
    • Lawson, Claire;
    • Routen, Ash;
    • Islam, Nazrul;
    • Razieh, Cameron;
    • Zaccardi, Francesco;
    • Yates, Tom;
    • Davies, Melanie J.;
    • Brightling, Christopher E.;
    • Chalmers, James D.;
    • Docherty, Annemarie B.;
    • Elneima, Omer;
    • Evans, Rachael A.;
    • Greening, Neil J.;
    • Harris, Victoria C.;
    • Harrison, Ewen M.;
    • Ho, Ling‐Pei;
    • Horsley, Alex
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 683, doi. 10.1111/dom.16062
    By:
    • Koh, Jaycie;
    • Mohamed, Ayman;
    • Kong, Gwyneth;
    • Wong, Esther;
    • Chen, Yiming;
    • Anand, Vickram Vijay;
    • Chong, Bryan;
    • Chin, Yip Han;
    • Wang, Jiong‐Wei;
    • Khoo, Chin Meng;
    • Chan, Siew Pang;
    • Muthiah, Mark;
    • Dimitriadis, Georgios K.;
    • Chan, Mark Yan‐Yee;
    • Loh, Poay‐Huan;
    • Chew, Nicholas W. S.
    Publication type:
    Article
    36
    37
    38
    39
    40

    De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D)

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 642, doi. 10.1111/dom.16057
    By:
    • Rodriguez, Paloma;
    • Breslaw, Nikki;
    • Xiao, Huijun;
    • Bena, Jim;
    • Jenkins, Kimberly;
    • Isaacs, Diana;
    • Zhou, Keren;
    • Griebeler, Marcio L.;
    • Burguera, Bartolome;
    • Pantalone, Kevin M.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 551, doi. 10.1111/dom.16047
    By:
    • Haggag, Amina Z.;
    • Xu, Jianfeng;
    • Butcher, Laurie;
    • Pagnussat, Sandra;
    • Davies, Graeme;
    • Lundqvist, Sara;
    • Wang, Wenyu;
    • Van Zuydam, Natalie;
    • Nelander, Karin;
    • Jha, Aruni;
    • Yu, Hongtao;
    • Boianelli, Alessandro;
    • Lindmark, Bosse;
    • Ollerstam, Anna;
    • Sun, Xuefeng;
    • Wang, Fan;
    • Pan, Xiaoliang;
    • Liu, Haihui;
    • Chen, Wengang;
    • Wallenius, Kristina
    Publication type:
    Article
    50